NPPES file of Aug 9, 2026

Ali-Reza Bazmi, PHARM.D.

Pharmacotherapy Pharmacist · Bakersfield, CA

Ali-Reza Bazmi, PHARM.D. is a pharmacotherapy pharmacist with a practice address in Bakersfield, California, and NPI 1235122946, issued on Aug 26, 2005. Check the license (California 44627, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1235122946
Name
Ali-Reza Bazmi
Credential
PHARM.D.
Primary taxonomy
Pharmacotherapy Pharmacist 1835P1200X
License number
44627 CA
Self-reported in NPPES; status is on the state search
Practice location
1700 Mount Vernon Ave, Bakersfield, CA 93306
Phone
(661) 326-2767
Enumerated
Aug 26, 2005
Record last updated
Jul 13, 2026
Fax
(661) 862-7672
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1700 Mount Vernon Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Pernian AbadiPrimary Care Nurse Practitioner1801760814
  2. Mariam AbdelmissehInternal Medicine Physician1902250574
  3. Arian AbdiStudent in an Organized Health Care Education/Training Program1306538087
  4. Ayham Aboeed, M.D.Critical Care Medicine (Internal Medicine) Physician1093969750
  5. Jesslin Abraham, MDStudent in an Organized Health Care Education/Training Program1497333751
  6. Quinn Adams, MDStudent in an Organized Health Care Education/Training Program1790627537

Verify Ali-Reza Bazmi in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 44627
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

57% fewer Medicare Part D claims than the average pharmacotherapy pharmacist in 2024

171 Medicare Part D claims for 34 beneficiaries, against an average of 395 among the 208 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims.

  1. Ali-Reza Bazmi171
  2. Specialty average395

Most prescribed

  1. Dexamethasone56 claims
  2. Ondansetron Hcl11 claims
  3. Prochlorperazine Maleate11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Ali-Reza Bazmi among 605 pharmacotherapy pharmacist records in California

Ali-Reza Bazmi, PHARM.D. is one of 605 pharmacotherapy pharmacist records with a practice address in California. 10% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2005, is newer than 0% of them.

  • NPI issued2005 · 0% of these records are older, 92% newer
  • In a Medicare fileYes · 10% of these records are
  • In the CMS Doctors and Clinicians fileNo · 0% of these records are
  • Record last updated2026 · 76% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1835P1200X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Pharmacotherapy Pharmacist providers in California

There are 605 pharmacotherapy pharmacist records in California.

The 8 pharmacotherapy pharmacist records with the nearest ZIP codes

  1. Elliott Asarch, PHARM.D.Bakersfield, CA 933061598132722
  2. Kernvir ChauhanBakersfield, CA 933061770984247
  3. Jasjinder Cheema, PHARM.D.Bakersfield, CA 933061841423241
  4. Bethany Dedonato, PHARM.D.Bakersfield, CA 933061174857627
  5. Jackie Ho, PHARM.D., MPHBakersfield, CA 933061407223753
  6. Karissa Jongsma, PHARM.D.Bakersfield, CA 933061659645968
  7. David Lash, PHARMDBakersfield, CA 933061649670993
  8. Angela Mack, PHARMDBakersfield, CA 933061356675334

Common questions

What is Ali-Reza Bazmi, PHARM.D.'s NPI number?

Ali-Reza Bazmi, PHARM.D.'s National Provider Identifier (NPI) is 1235122946, issued on Aug 26, 2005. An NPI identifies a provider in billing; it is not a license.

Where is Ali-Reza Bazmi, PHARM.D. located?

The NPPES record lists a practice address at 1700 Mount Vernon Ave, Bakersfield, CA, 93306. Phone: (661) 326-2767. Providers update this record themselves, so call before visiting.

How can I verify Ali-Reza Bazmi, PHARM.D.'s license?

NPPES lists California license number 44627, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

How much does Ali-Reza Bazmi, PHARM.D. prescribe under Medicare Part D?

In 2024, Ali-Reza Bazmi, PHARM.D. had 171 Medicare Part D claims for 34 beneficiaries; the average among pharmacotherapy pharmacist prescribers was 395. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.